Skip to content

Influence of Strength Training and Protein Supplementation on Fitness of Institutionalized Elderly

Influence of Strength Training and Nutritional Supplementation on Physical Performance and Well-being of Older People in Pensioner Homes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01775111
Enrollment
120
Registered
2013-01-24
Start date
2012-01-31
Completion date
Unknown
Last updated
2013-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

strength training, protein supplementation, sarcopenia

Brief summary

The aim of this randomized, observer-blind, controlled intervention study with parallel groups is to study the effect of strength training (2x/week for 6 months) with and without additional dietary supplementation (protein-enriched) on muscle strength, function and mass, oxidative stress parameters and the immune system in elderly institutionalized persons. The participants (n = 120) are recruited from Viennese senior residencies (Kuratorium Wiener Pensionistenwohnheime). After a pre-participation screening participants will be distributed randomly but stratified by sex and age to one of the 3 intervention groups (cognitive training, strength training, strength training + supplement). Study participants are eligible if they are male or female with an age over 65 years and if their cognitive status as well as their physical fitness level allows to participate at the strength training sessions. Exclusion criteria comprise chronic diseases which contraindicate the medical training therapy, serious cardiovascular disease, diabetic retinopathy and manifest osteoporosis, medication with anticoagulants or cortisone drugs and also regular strength training during the last six months. Primary outcome measure is the change in isokinetic torque of knee extensors. Secondary outcome measures comprise anthropometric data, functional performance tests, immunological and oxidative stress parameters. The change in muscle signaling pathways will be assessed from muscle biopsies.

Interventions

BEHAVIORALCognitive Training
BEHAVIORALStrength Training
DIETARY_SUPPLEMENTFortiFit

Sponsors

Kaiser Franz Josef Hospital
CollaboratorOTHER
University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State \>23) * Ability to walk 10 meters independently (without orthopaedic devices) * 4 or more points at the Short Physical Performance Battery

Exclusion criteria

* Chronic diseases, which contraindicate a medical training therapy * Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias) * Diabetic retinopathy * Manifest osteoporosis * Regular use of cortisone-containing drugs * Regular strength training (\> 1x / week) in the last 6 months before inclusion

Design outcomes

Primary

MeasureTime frame
change from baseline in isokinetic torque of knee extensorsbaseline and 6 months

Secondary

MeasureTime frame
change from baseline in 6min walking testbaseline and 6 months
change from baseline in handgrip strengthbaseline and 6 months
change from baseline in single leg balance standbaseline and 6 months
change from baseline in lean body massbaseline and 6 months
change from baseline in DNA strand breaksbaseline and 6 months
change from baseline in high-sensitive C reactive proteinbaseline and 6 months
change from baseline in muscular myostatin expressionbaseline and 6 months

Other

MeasureTime frame
change from baseline in isokinetic torque of knee extensors at 12 monthsbaseline and 12 months
change from baseline in isokinetic torque of knee extensors at 18 monthsbaseline and 18 months

Countries

Austria

Contacts

Primary ContactMichael Quittan, Prim. Univ.Prof. Dr.
michael.quittan@wienkav.at+43160191
Backup ContactBarbara Wessner, Ass.-Prof. DI Dr.
barbara.wessner@univie.ac.at+4314277

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026